Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug
Astellas Pharma already has the primary FDA approval for a remedy that goes after Claudin 18.2, a protein whose overexpression ...
Astellas Pharma already has the primary FDA approval for a remedy that goes after Claudin 18.2, a protein whose overexpression ...
Most cancers is effectively represented within the Astellas Pharma portfolio and pipeline, however the drugmaker has made diversification a key ...
An Astellas Pharma drug designed to deal with a novel goal has landed a extremely anticipated FDA approval for a ...
Cambodia late final week reported its sixth case and fifth dying from H5N1 avian flu this 12 months, in line with...
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.